EUVIMEDSkopri EUVIMED
Vergleichsstudie

Markers for OLN-93 oligodendroglia differentiation

Marieke E van Meeteren, Marleen A Koetsier, Christine D Dijkstra, Eric A F van Tol

Developmental Brain Research · 2005-04 · 156 (1) · 78-86

DOI: 10.1016/j.devbrainres.2005.02.005 ↗

At a glance

Vergleichsstudie in Developmental Brain Research, 2005-04. Written by Marieke E van Meeteren and 3 co-authors. Institution: Numico Research B.V., Biomedical Research Department, PO Box 7005, 6700 CA Wageningen, The Netherlands. Cited 7 times so far (Crossref); 39 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Oligodendrocytes are target cells in the pathogenesis of multiple sclerosis (MS), a chronic demyelinating disease of the central nervous system (CNS). During the course of the disease, inflammatory mediators may damage oligodendrocytes and their myelin sheaths. Differentiation of oligodendrocyte progenitors is an important step in the process of remyelination. In the present study, OLN-93 differentiation was studied in co-culture with C6 astrocytes as a natural source of growth and differentiation factors as well as after exposure to insulin-like growth factor-I (IGF-I). Morphological evaluation showed an increased degree of differentiation of OLN-93 cells after IGF-I administration, but not after co-culture with astrocytes. During early differentiation, 2', 3'-cyclic nucleotide 3'-phosphohydrolase (CNP) and zonula occludens-1 (ZO-1) tight junction protein expression were significantly increased. However, neither astrocyte co-culture nor exposure to IGF-I further increased the expression of these markers. Although reverse transcriptase-polymerase chain reaction revealed myelin basic protein (MBP) mRNA expression not to be affected during differentiation, we did find increased MBP protein expression by Western blotting. ZO-1 protein and DM20 mRNA levels were increased during the course of differentiation and after IGF-I administration. The present findings suggest that ZO-1 may be used as a marker for OLN-93 oligodendroglia differentiation.

Subjects

MeSH terms (MEDLINE)

AnimalsAstrocytesBiomarkersBlotting, WesternCell DifferentiationCell LineCoculture TechniquesFluorescent Antibody TechniqueInsulin-Like Growth Factor IMembrane ProteinsModels, BiologicalMyelin Basic ProteinMyelin Proteolipid ProteinNerve Tissue ProteinsNucleoside-TriphosphataseOligodendrogliaPhosphoproteinsRNA, MessengerRatsReverse Transcriptase Polymerase Chain Reaction

Substances

BiomarkersMembrane ProteinsMyelin Basic ProteinMyelin Proteolipid ProteinNerve Tissue ProteinsPhosphoproteinsPlp1 protein, ratRNA, MessengerTjp1 protein, ratZonula Occludens-1 Protein

Authors and institutions

  • Numico Research B.V., Biomedical Research Department, PO Box 7005, 6700 CA Wageningen, The Netherlands.

Cite

APA

van Meeteren, M. E., Koetsier, M. A., Dijkstra, C. D., & van Tol, E. A. (2005). Markers for OLN-93 oligodendroglia differentiation. Developmental Brain Research, 156(1), 78-86. https://doi.org/10.1016/j.devbrainres.2005.02.005

Vancouver

van Meeteren ME, Koetsier MA, Dijkstra CD, van Tol EA. Markers for OLN-93 oligodendroglia differentiation. Developmental Brain Research. 2005;156(1):78-86. doi:10.1016/j.devbrainres.2005.02.005

BibTeX
@article{vanMeeteren2005,
  author = {van Meeteren, Marieke E and Koetsier, Marleen A and Dijkstra, Christine D and van Tol, Eric A F},
  title = {Markers for OLN-93 oligodendroglia differentiation},
  journal = {Developmental Brain Research},
  year = {2005},
  volume = {156},
  number = {1},
  pages = {78--86},
  doi = {10.1016/j.devbrainres.2005.02.005}
}
Start for free →